Navigating the procurement of high-purity synthetic short peptides for central nervous system research requires rigorous quality verification and reliable supply chains. PX1 Research provides institutional laboratories with analytical-grade Cortagen (Ala-Glu-Asp-Pro), fully validated via third-party chromatography and mass spectrometry for in vitro and animal models.
Navigating the procurement of high-purity synthetic short peptides for central nervous system research requires rigorous quality verification and reliable supply chains. PX1 Research provides institutional laboratories with analytical-grade Cortagen (Ala-Glu-Asp-Pro), fully validated via third-party chromatography and mass spectrometry for in vitro and animal models.
To buy research-grade Cortagen, primary investigators must partner with certified chemical suppliers offering high-purity, USA-manufactured synthetic peptides validated via third-party HPLC and mass spectrometry. PX1 Research supplies analytical-grade Cortagen (Ala-Glu-Asp-Pro) accompanied by lot-specific Certificates of Analysis, verifying purity equal to or exceeding 98% and low endotoxin levels strictly for in vitro and preclinical research applications.
When evaluating a supplier for central nervous system (CNS) research compounds, laboratory procurement officers must prioritize verified sequence identity, batch-to-batch consistency, and robust analytical documentation over unverified market claims. Inconsistent peptide purity or residual manufacturing contaminants can alter receptor binding kinetics, confound gene expression profiling, and invalidate cell culture assays. PX1 Research eliminates these variables by maintaining strict synthesis protocols in GMP-compliant facilities and housing all physical stock in temperature-controlled California and Arizona hubs for rapid distribution.
Cortagen is a synthetic short peptide composed of four amino acids with the chemical sequence L-alanyl-L-glutamyl-L-aspartyl-L-proline (Ala-Glu-Asp-Pro). Belonging to the class of biomimetic peptide bioregulators, Cortagen was developed to model the targeted activity of endogenous neural tissue-derived peptide complexes. With a molecular weight of approximately 432.4 g/mol, its low molecular mass facilitates rapid diffusion across cellular membranes in in vitro experimental environments.
The molecular architecture of Cortagen includes acidic amino acid residues (glutamic acid and aspartic acid) paired with proline at the C-terminus. This specific spatial conformation is hypothesized to govern its interaction with nuclear chromatin and DNA histone structures. Research facilities investigating peptide-chromatin interactions utilize Cortagen as a standard model for analyzing short-chain peptide-mediated gene regulation without the complex tertiary folding dynamics present in larger proteins.
Preclinical studies suggest that Cortagen exerts neuroprotective effects primarily by modulating inflammatory cascades, oxidative stress pathways, and apoptotic signaling in neural cells. In rodent models of cerebral ischemia and traumatic brain injury, administration of Cortagen was observed to reduce ischemic lesion volume and suppress the overactivation of pro-inflammatory cytokines, including interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).
In vitro data indicate that Cortagen exposure enhances neuron survival under conditions of hydrogen peroxide-induced oxidative damage. Researchers measuring mitochondrial membrane potential and caspase-3 activity have observed that Cortagen downregulates pro-apoptotic proteins such as Bax while upregulating anti-apoptotic markers such as Bcl-2. These biochemical shifts suggest a protective mechanism focused on stabilizing mitochondrial integrity during metabolic or hypoxic stress.
Beyond classical cell-surface receptor signaling, short peptide bioregulators are investigated for their ability to influence genomic expression directly within the cell nucleus. Spectroscopic and molecular docking studies indicate that peptides like Cortagen can bind to specific sequence motifs in double-stranded DNA, altering the accessibility of promoter regions to RNA polymerase enzyme complexes.
In experimental models evaluating neuronal differentiation and plastic adaptation, Cortagen has been shown to modulate the transcription of neurotrophic factors, including Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF). By measuring mRNA transcript levels via quantitative real-time PCR (qPCR), investigators aim to map the temporal dynamics of Cortagen-induced genomic responses in primary cortical neuron cultures and astrocyte co-cultures.
When structuring comparative neurobiology experiments, investigators frequently evaluate Cortagen alongside other synthetic short-chain peptides and neuroactive regulatory compounds. Understanding the distinct structural profiles and primary mechanisms across these agents allows research teams to select the appropriate compound for their specific assays.
Cortagen (Ala-Glu-Asp-Pro) is distinct in its acidic tetrapeptide structure focused primarily on neuroprotection and inflammatory modulation in brain tissue models. In comparison, Pinealon is a synthetic tripeptide (Glu-Asp-Arg) evaluated for its regulatory effects on circadian rhythm genes and reactive oxygen species (ROS) neutralization in pineal and cortical cell lines. Meanwhile, regulatory peptides like Semax and Selank feature longer peptide chains derived from ACTH and tuftsin respectively, targeting central melanocortin receptors and GABAergic neurotransmission. For broader regenerative models, researchers often contrast these bioregulators with non-peptide small molecules like Dihexa or systemic peptides such as Epithalon.
Verifying the purity of synthetic peptides is essential for maintaining experimental reproducibility across laboratory trials. Low-grade peptides frequently contain deletion sequences, truncated peptides, and residual trifluoroacetic acid (TFA) salts that interfere with cellular assays. PX1 Research enforces strict analytical standards by subjecting every batch of Cortagen to rigorous third-party verification.
Primary analytical protocols include High-Performance Liquid Chromatography (HPLC) to establish chemical purity and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular mass. A lot-specific Certificate of Analysis (COA) is published for every inventory batch, documenting purity levels equal to or exceeding 98%. Researchers can access these transparent laboratory reports directly through our research library hub prior to ordering.
For cell culture assays, primary cell isolation, and microfluidic organ-on-a-chip models, endotoxin contamination presents a significant risk of experimental error. Bacterial lipopolysaccharides (LPS) induce microglial activation, mask subtle neuroprotective effects, and cause unintended cell death in delicate neuronal lines.
PX1 Research ensures all synthesized batches intended for laboratory applications undergo quantitative Limulus Amebocyte Lysate (LAL) testing to verify low endotoxin levels (typically <0.05 EU/mg). This stringent endotoxin limit guarantees that experimental responses measured in neural assays stem directly from the test compound rather than unwanted pyrogenic contaminants.
Proper handling of lyophilized peptides is critical to maintain structural stability and prevent premature degradation. Cortagen is supplied as a sterile, lyophilized white powder sealed under inert gas. Upon receipt, unopened vials should be stored in a freezer at -20°C for short-term preservation or -80°C for long-term storage, protected from light and moisture exposure.
For laboratory reconstitution, researchers should allow the vial to equilibrate to room temperature before adding sterile, nuclease-free water or phosphate-buffered saline (PBS, pH 7.4). Avoid vigorous vortexing; instead, gently swirl the vial until the cake is fully dissolved. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene tubes to minimize freeze-thaw cycles and stored at -80°C. Working solutions in aqueous buffers are recommended to be used within 24 to 48 hours when maintained at 4°C.
Selecting a reliable supplier for research-grade peptides requires evaluating the vendor’s manufacturing facilities, domestic logistics, and quality assurance frameworks. Importers relying on unverified overseas vendors often face unpredictable shipping delays, compromised cold-chain storage, and variable quality between production batches.
PX1 Research operates exclusively within a domestic supply chain architecture, utilizing USA-based synthesis facilities compliant with current Good Manufacturing Practices (cGMP) and testing through ISO 17025 accredited analytical laboratories. Orders are fulfilled same-day (Monday through Friday) from centralized fulfillment centers in California and Arizona, providing institutional buyers with consistent delivery schedules, intact cold chains, and reliable batch traceability.
Academic institutions, biotechnology organizations, and independent research laboratories can source Cortagen directly through the PX1 Research digital platform. We accommodate both small-scale screening projects and high-throughput preclinical study designs with flexible quantity options.
For high-volume requirements or multi-center research programs, laboratories can establish wholesale research accounts to streamline procurement, lock in volume pricing, and secure reserved batch allocations. Explore our complete collection of verified reagents across all research peptides to support your lab's ongoing neurobiology and biochemical investigations.
What is Cortagen and what is its chemical sequence?
Cortagen is a synthetic tetrapeptide bioregulator with the amino acid sequence Ala-Glu-Asp-Pro (L-alanyl-L-glutamyl-L-aspartyl-L-proline). It is supplied strictly for in vitro and laboratory research applications investigating neuronal tissue pathways.
How does PX1 Research verify the purity of Cortagen?
Every lot of Cortagen undergoes third-party testing using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity assessment and Mass Spectrometry (MS) for sequence verification. Detailed COAs showing ≥98% purity are provided for every lot.
What is the recommended storage temperature for lyophilized Cortagen?
Lyophilized Cortagen powder should be stored at -20°C for standard storage or -80°C for extended long-term storage, protected from light, moisture, and ambient temperature fluctuations.
What diluent should be used to reconstitute Cortagen for in vitro assays?
Cortagen can be reconstituted using sterile laboratory-grade water, sterile physiological saline, or standard Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of the downstream cell culture or cell-free assay.
How does Cortagen compare to Pinealon in preclinical research?
Cortagen is a tetrapeptide (Ala-Glu-Asp-Pro) studied primarily for anti-inflammatory and anti-apoptotic signaling in brain tissue, whereas Pinealon is a tripeptide (Glu-Asp-Arg) focused on circadian gene expression and oxidative stress reduction in neuronal cell lines.
What are the endotoxin limits for Cortagen supplied by PX1 Research?
PX1 Research subjects research peptides to Limulus Amebocyte Lysate (LAL) endotoxin testing, ensuring levels remain below 0.05 EU/mg to prevent endotoxin-induced background artifacts in cell culture models.
Is Cortagen approved for human therapeutic or clinical use?
No. Cortagen is sold strictly as a chemical reference compound for in vitro, biochemical, and preclinical laboratory research. It is not approved for human consumption, therapeutic use, or clinical administration.
Where does PX1 Research ship Cortagen orders from?
All PX1 Research orders are fulfilled from USA-based facilities located in California and Arizona, with same-day shipping available for orders placed Monday through Friday before cut-off times.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.